| Financial Year |
March 31 2023 |
| Monetary Funds |
127,319,043.08 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
99,604,610.47 |
| Advances to Suppliers |
15,709,262.34 |
| Other Receivables |
10,848,570.24 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
67,628,517.32 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
3,393,046.92 |
| Total Current Assets |
324,503,050.37 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
17,312,526.63 |
| Investment Properties |
-- |
| Fixed Assetes |
179,474,424.39 |
| Under-construction Projects |
8,630,746.85 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
84,994,037.40 |
| R&D expenses |
15,959,807.28 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
7,485,563.52 |
| Deferred Income Tax Assets |
13,101,398.81 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
369,167,515.15 |
| Total Assets |
693,670,565.52 |
| Short-Term Loans |
48,047,208.20 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
4,597,099.31 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
8,624,415.36 |
| Taxes Payable |
21,942,419.35 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
69,066,694.01 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
7,710,865.03 |
| Other Current Liabilities |
1,709,555.78 |
| Sub-Total of Current Liabilities |
188,624,677.19 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
4,983,308.37 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
48,361,050.30 |
| Total Liabilities |
236,985,727.49 |
| Paid-In Capital(Or Share Stock) |
265,155,701.00 |
| Capital Surplus |
600,268,565.98 |
| Surplus Reserve |
43,851,701.31 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-351,143,371.93 |
| Minority Stockholder's Interest |
-52,471,592.87 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
509,156,430.90 |
| Owner's Equity（Stockholder's Equity） |
456,684,838.03 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
693,670,565.52 |
